Pseudolymphoma syndrome revisited

Indian Journal of Dermatology, Venereology and Leprology

Volumn 70, Issue 1, 2004, Pages 48-51

  Goel, Ashima ^a,b   Walia, R L S ^a  

^a Rajindra Hospital   (India)

^b NONE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; AMPICILLIN; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; CD4 ANTIGEN; CD8 ANTIGEN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTOCHROME P450 3A; FELBAMATE; GABAPENTIN; IMMUNOGLOBULIN; INTERLEUKIN 5; LAMOTRIGINE; METHYLPREDNISOLONE; NORMEPHENYTOIN; OXIDE; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; SULFADIAZINE SILVER; SULFANILAMIDE; VALPROIC ACID;

AMINO ACID SEQUENCE; ARTHRALGIA; ARTICLE; CYTOKINE PRODUCTION; DRUG HYPERSENSITIVITY; FEVER; HEMATOLOGIC DISEASE; HEPATITIS; HUMAN; LEUKOCYTOCLASTIC VASCULITIS; LUNG DISEASE; LYMPHADENOPATHY; MORTALITY; MYALGIA; NEPHRITIS; NONHUMAN; PERIORBITAL EDEMA; PHARYNGITIS; PLASMAPHERESIS; PROGNOSIS; PSEUDOLYMPHOMA; RASH; SITE DIRECTED MUTAGENESIS; STEVENS JOHNSON SYNDROME; TOXIC EPIDERMAL NECROLYSIS;

EID: 33646477393     PISSN: 03786323     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Silber IB, Epstein JW. The treatment of chorea with phenylethylhydantoin: a study of 28 cases. Arch Pediatr 1934;51:373-82.
2. Chaiken BH, Goldberg BI, Segal JP. Dilantin sensitivity: report of a case of hepatitis with jaundice, pyrexia, and exfoliative dermatitis. N Engl J Med 1950;242:897-8.
3. Shear NH, Spielberg SP. Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk. J Clin Invest 1988;82:1826-32.
4. Manders SM. Serious and life-threatening drug eruptions. Am Fam Physician 1995;51:1865-72.
5. Conger LA Jr, Grabski WJ. Dilantin hypersensitivity reaction. Cutis. 1996;57:223-6.
6. Brown CE, Smith GD, Coniglione T. Anticonvulsant hypersensitivity: an unfortunate case of triple exposure to phenytoin. J Fam Pract 1997;45:434-7.
7. Tennis P, Stern RS. Risk of serious cutaneous disorders after initiation of use of phenytoin, carbamazepine, or sodium valproate: a record linkage study. Neurology 1997;49:542-6.
8. Schlienger RG, Shear NH. Antiepileptic drug hypersensitivity syndrome. Epilepsia 1998;39(Suppl 7):S3-S7.
9. Cupp, MJ, Tracy TS. Cytochrome P450: new nomenclature and clinical implications. Am Fam Physician 1998;57:107-16.
10. Singer MI, Shapiro LE, Shear NH. Cytochrome P-450 3A: interactions with dermatologic therapies. J Am Acad Dermatol 1997;37:765-71.
11. Leeder JS. Mechanisms of idiosyncratic hypersensitivity reactions to antiepileptic drugs. Epilepsia 1998;39(Suppl 7):S8-S16.
12. Descamps V, Bouscarat F, Laglenne S, Aslangul E, Veber B, Descamps D, et al. Human herpesvirus 6 infection associated with anticonvulsant hypersensitivity syndrome and reactive haemophagocytic syndrome. Br J Dermatol 1997;137:605-8.
13. Roujeau JC, Stern RS. Severe adverse cutaneous reactions to drugs. N Engl J Med 1994;331:1272-85.
14. Mauri-Hellweg D, Bettens F, Mauri D, Brander C, Hunziker T, Pichler WJ. Activation of drug-specific CD4+ and CD8+ T cells in individuals allergic to sulfonamides, phenytoin, and carbamazepine. J Immunol 1995;155:462-72.
15. Schlienger RG, Shapiro LE, Shear NH. Lamotrigine-induced severe cutaneous adverse reactions. Epilepsia 1998;39:(Suppl 7):S22-S26.
16. Vittorio CC, Muglia JJ. Anticonvulsant hypersensitivity syndrome. Arch Intern Med 1995;155:2285-90.
17. Angle P, Thomas P, Chiu B, Freedman J. Bronchiolitis obliterans with organizing pneumonia and cold agglutinin disease associated with phenytoin hypersensitivity syndrome. Chest 1997;112:1697-9.
18. Bocquet H, Bagot M, Roujeau JC. Drug-induced pseudolymphoma and drug hypersensitivity syndrome (drug rash with eosinophilia and systemic symptoms: DRESS). Semin Cutan Med Surg 1996;15:250-7.
19. Rosenthal CJ, Noguera CA, Coppola A, Kapelner SN. Pseudolymphoma with mycosis fungoides manifestations, hyperresponsiveness to diphenylhydantoin, and lymphocyte disregulation. Cancer 1982;49:2305-14.
20. Rijlaarsdam U, Scheffer E, Meijer CJ, Kruyswijk MR, Willemze R. Mycosis fungoides-like lesions associated with phenytoin and carbamazepine therapy. J Am Acad Dermatol 1991;24:216-20.
21. Singer L, Brook U, Romem M, Fried D. Vitamin A in Stevens-Johnson syndrome. Ann Ophthalmol 1989;21:209-10.
22. Cheriyan S, Patterson R, Greenberger PA, Grammer LC, Latall J. The outcome of Stevens-Johnson syndrome treated with corticosteroids. Allergy Proc 1995;16:151-5.
23. Kamanabroo D, Schmitz-Landgraf W, Czarnetzki BM. Plasmapheresis in severe drug-induced toxic epidermal necrolysis. Arch Dermatol 1985;121:1548-9.
24. Eastham JH, Segal JL, Gomez MF, Cole GW. Reversal of erythema multiforme major with cyclophosphamide and prednisone. Ann Pharmacother 1996;30:606-7.
25. Renfro L, Grant-Kels JM, Daman LA. Drug-induced toxic epidermal necrolysis treated with cyclosporine. Int J Dermatol 1989;28:441-4.
26. Moudgil A, Porat S, Brunnel P, Jordan SC. Treatment of Stevens-Johnson syndrome with pooled human intravenous immune globulin. Clin Pediatr 1995;34:48-51.